Takahiro Fukuda


Ontology type: schema:Person     


Person Info

NAME

Takahiro

SURNAME

Fukuda

Publications in SciGraph latest 50 shown

  • 2022-09-12 Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2022-09-01 Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation in JOURNAL OF CANCER SURVIVORSHIP
  • 2022-08-20 Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation in BONE MARROW TRANSPLANTATION
  • 2022-06-02 Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-05-10 Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-03-28 Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL in LEUKEMIA
  • 2022-03-24 Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents in BONE MARROW TRANSPLANTATION
  • 2022-01-28 Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-01-28 Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-01-23 Long-term follow-up of patients with ATL after autologous stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2022-01-21 Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2022-01-17 Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group in BONE MARROW TRANSPLANTATION
  • 2022-01-15 Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia–lymphoma in ANNALS OF HEMATOLOGY
  • 2022-01-06 Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2021-11-27 Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors in SUPPORTIVE CARE IN CANCER
  • 2021-11-24 Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia in LEUKEMIA
  • 2021-11-24 Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies in BONE MARROW TRANSPLANTATION
  • 2021-10-21 Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers in BMC CANCER
  • 2021-10-08 Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation in BONE MARROW TRANSPLANTATION
  • 2021-09-24 Altered effect of killer immunoglobulin-like receptor–ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation in BONE MARROW TRANSPLANTATION
  • 2021-09-24 Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis in BLOOD CANCER JOURNAL
  • 2021-09-07 Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group in ANNALS OF HEMATOLOGY
  • 2021-09-07 Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis in BONE MARROW TRANSPLANTATION
  • 2021-09-03 The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia in ANNALS OF HEMATOLOGY
  • 2021-09-03 Impact of HLA disparity on the risk of overall mortality in patients with grade II–IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2021-08-31 Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma in BONE MARROW TRANSPLANTATION
  • 2021-08-27 Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up in JOURNAL OF CANCER SURVIVORSHIP
  • 2021-08-10 Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma in NATURE COMMUNICATIONS
  • 2021-07-30 Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation—a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT in BONE MARROW TRANSPLANTATION
  • 2021-07-30 Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-07-16 Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission in BONE MARROW TRANSPLANTATION
  • 2021-06-21 Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status in BONE MARROW TRANSPLANTATION
  • 2021-05-15 Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients in BONE MARROW TRANSPLANTATION
  • 2021-05-14 Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2021-05-11 Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence in BONE MARROW TRANSPLANTATION
  • 2021-05-07 Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors in BONE MARROW TRANSPLANTATION
  • 2021-04-29 Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-04-19 Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study in BONE MARROW TRANSPLANTATION
  • 2021-03-07 Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-03-03 Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-03-03 Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies in BONE MARROW TRANSPLANTATION
  • 2021-02-24 Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation in GENES & IMMUNITY
  • 2021-02-21 Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-02-11 Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-01-29 Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2021-01-07 Characterization of readmission after allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-01-03 Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-12-02 Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes in BONE MARROW TRANSPLANTATION
  • 2020-10-09 Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors in BONE MARROW TRANSPLANTATION
  • 2020-10-08 Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.272242.3", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416006.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.177174.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411248.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411873.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.69566.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.489169.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.258269.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410813.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.31432.37", 
            "type": "Organization"
          }
        ], 
        "familyName": "Fukuda", 
        "givenName": "Takahiro", 
        "id": "sg:person.016452523632.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016452523632.46"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-10-01T07:17", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/person/person_753.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.016452523632.46'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.016452523632.46'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.016452523632.46'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.016452523632.46'


     

    This table displays all metadata directly associated to this object as RDF triples.

    40 TRIPLES      10 PREDICATES      23 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.016452523632.46 schema:affiliation N53f70a30f79541c2919101d3c2d0cee5
    2 grid-institutes:grid.177174.3
    3 grid-institutes:grid.258269.2
    4 grid-institutes:grid.26999.3d
    5 grid-institutes:grid.270240.3
    6 grid-institutes:grid.31432.37
    7 grid-institutes:grid.410813.f
    8 grid-institutes:grid.410914.9
    9 grid-institutes:grid.411248.a
    10 grid-institutes:grid.411873.8
    11 grid-institutes:grid.416006.5
    12 grid-institutes:grid.489169.b
    13 grid-institutes:grid.69566.3a
    14 schema:familyName Fukuda
    15 schema:givenName Takahiro
    16 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016452523632.46
    17 schema:sdDatePublished 2022-10-01T07:17
    18 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    19 schema:sdPublisher Nb68f9d331fe042a2bc02c482e729842e
    20 sgo:license sg:explorer/license/
    21 sgo:sdDataset persons
    22 rdf:type schema:Person
    23 N53f70a30f79541c2919101d3c2d0cee5 schema:affiliation grid-institutes:grid.272242.3
    24 sgo:isCurrent true
    25 rdf:type schema:OrganizationRole
    26 Nb68f9d331fe042a2bc02c482e729842e schema:name Springer Nature - SN SciGraph project
    27 rdf:type schema:Organization
    28 grid-institutes:grid.177174.3 schema:Organization
    29 grid-institutes:grid.258269.2 schema:Organization
    30 grid-institutes:grid.26999.3d schema:Organization
    31 grid-institutes:grid.270240.3 schema:Organization
    32 grid-institutes:grid.272242.3 schema:Organization
    33 grid-institutes:grid.31432.37 schema:Organization
    34 grid-institutes:grid.410813.f schema:Organization
    35 grid-institutes:grid.410914.9 schema:Organization
    36 grid-institutes:grid.411248.a schema:Organization
    37 grid-institutes:grid.411873.8 schema:Organization
    38 grid-institutes:grid.416006.5 schema:Organization
    39 grid-institutes:grid.489169.b schema:Organization
    40 grid-institutes:grid.69566.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...